| API | Isem tal-Prodott | KAŻ NRU. | Klassifikazzjoni |
| Ceritinib/Crizotinib | (R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine | 877399-00-3 | Kontra l-kanċer |
| Alpelisib | 2-(1,1,1-trifluoro-2-Methylpropan-2-yl)-4H-pyran-4-one | 1357476-64-2 | Kontra l-kanċer |
| Alpelisib | 2-(1,1,1-trifluoro-2-Methylpropan-2-yl)pyridin-4(1H)-one | 1357476-66-4 | Kontra l-kanċer |
| Apalutami | 4-amino-2-fluoro-N-methylbenzamide | 915087-25-1 | Kontra l-kanċer |
| Apalutami | 5-Nitro-3-trifluoroMethylpyridine-2-carbonitrile | 573762-57-9 | Kontra l-kanċer |
| Apalutami | 4-amino-2-fluoro-N-methylbenzamide | 915087-25-1 | Kontra l-kanċer |
| Apalutami | 5-Amino-3-(trifluorometil)piridin-2-karbonitrile | 573762-62-6 | Kontra l-kanċer |
| Cabozantinib | 4-Hydroxy-6,7-dimethoxyqunioline | 13425-93-9 | Kontra l-kanċer |
| Cabozantinib | Aċidu 1,1-Cyclopropanedicarboxylic | 598-10-7 | Kontra l-kanċer |
| Cabozantinib | 1-(4-FLUOROPHENYLCARBAMOYL)ĊIKLOPROPANEKARBOXYLIC ACID | 849217-48-7 | Kontra l-kanċer |
| Cabozantinib | 4-Chloro-6,7-dimethoxyquioline | 35654-56-9 | Kontra l-kanċer |
| Carfilzomib | Methyl3-formyl-2-nitrobenzoate | 138229-59-1 | Kontra l-kanċer |
| Carfilzomib | (S)-4-(tert-Butoxycarbonylamino)-2,6-dimethyl-1-hepten-3-one | 247068-81-1 | Kontra l-kanċer |
| Fulvestrant | (7a,17b)-7-[9-[(4,4,5,5,5-pentafluoropentil)sulfinil]nonil]estra-1,3,5(10)-triene-3,17-diol | 129453-61-8 | Kontra l-kanċer |
| LOXO-292 | 4-(6-Fluoropyridin-3-yl)-6-hydroxypyrazolo[1,5-a]pyridine-3-carbonitrile | 2222654-09-1 | Kontra l-kanċer |
| Methotrexate | 5-Nitroso-2,4,6-triaminopyrimidine | 1006-23-1 | Kontra l-kanċer |
| Neratinib | trans-4-Dimethylaminocrotonic acid hydrochloride | 848133-35-7 | Kontra l-kanċer |
| Neratinib | 2-oxoindole-6-carboxylate tal-metil | 14192-26-8 | oħrajn |
| Neratinib | N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide | 262368-30-9 | oħrajn |
| Neratinib | Trimethyl orthobenzoate | 707-07-3 | oħrajn |
| Osimertinib | 4-fluoro-2-Methoxy-5-nitroaniline | 1075705-01-9 | Kontra l-kanċer |
| Pirfenidone | 2-Amino-5-methylpyridine | 1603-41-4 | Kontra l-kanċer |
| Lenvatinib | 4-chloro-7-Methoxyquinoline-6-carboxaMide | 417721-36-9 | Kontra l-kanċer |
| Lenvatinib | 4-Amino-3-chlorophenol | 17609-80-2 | Kontra l-kanċer |
| Lenvatinib | 1-(2-chloro-4-hydroxyphenyl)-3-cyclopropylurea | 796848-79-8 | Kontra l-kanċer |
| Lenvatinib | 4-Amino-3-chlorophenol hydrochloride | 52671-64-4 | Antibijotiċi |
| Meropenem | 4AA: 4-Acetoxy-2-azetidinone | 28562-53-0 | Antibijotiċi |
| Meropenem | MAP (Beta-Methyl vinyl fosfat) | 90776-59-3 | Antibijotiċi |
| Cefuroxime | Klorur tal-metossiammonju | 593-56-6 | Antibijotiċi |
| Clotrimazole/Diclofenazole Econazole/Ketoconazole | Imidazole | 288-32-4 | Antibijotiċi |
| Doxycycline hyclate | DOXYCYCLINE IDROKLORUR, VETRANAL | 24390-14-5 | Antibijotiċi |
| Posaconazole | (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester | 149809-43-8 | Antibijotiċi |
| Posaconazole | 2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2 ,4-Triazol-3-one, | 184177-83-1 | Antibijotiċi |
| sheprevent | (2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl) glycyl-3-methyl-L-valine | 402958-96-7 | Antivirus |
| Entecavir | 6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2 -amina | 142217-80-9 | Antivirus |
| Famciclovir | 9-(4-Aċetossi-3-aċetossimetilbutil)-2-amino-6-kloropurina | 97845-60-8 | Antivirus |
| Lusuthrombopag | (E)-3,5-dikloro-4-(3-etossi-2-metil-3-oxoprop-1-enil)benżojku | 1110767-89-9 | Antivirus |
| Lusuthrombopag | (S)-4-(3-(1-(hexyloxy)ethyl)-2-methoxyphenyl)thiazol-2-amine | 1110767-98-0 | Antivirus |
| Linezolid | Linezolid | 165800-03-3 | Antivirus |
| Pregabalin | Aċidu 3-Carbamoymethyl-5-methylhexanoic | 181289-15-6 | sistema nervuża ċentrali |
